{
  "id": 6051702,
  "title": "Arrowhead Pharmaceuticals Director Sells 11,600 Shares for $1 Million",
  "url": "https://urgent.news/2026/09/06/arrowhead-pharmaceuticals-director-sells-11-600-shares-for-1-million",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-06T21:55:01.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/coverage/filings/2026/09/06/arrowhead-pharmaceuticals-director-sells-11-600-shares-for-usd1-million/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "Michael S. Perry, a Director at Arrowhead Pharmaceuticals, sold 11,600 shares of the company's common stock on August 18, 2026, according to an SEC Form 4 filing. The transaction's value was calculated at $1 million based on a weighted average sale price of $87.30 per share. The post-transaction value, calculated using the market close price of $87.90 per share, amounted to $1,017,900. Arrowhead Pharmaceuticals, a clinical-stage biopharmaceutical company founded in 1989 and headquartered in Pasadena, California, has a market capitalization of $12.2 billion and employs 711 people. The company specializes in RNAi-based therapeutics, an innovative approach to treating genetic and metabolic disorders that currently lack effective treatment options. Arrowhead Pharmaceuticals generated $669.5 million in revenue during the trailing twelve months (TTM) period and continues to invest in its pipeline of potential treatments. Despite the capital-intensive nature of biopharmaceutical development, the company remains optimistic about the potential success and commercialization of its clinical candidates, which could generate significant value for shareholders.",
  "summary": "Perry's liquidity event comes as the Arrowhead stock price surged.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Yahoo Finance",
        "title": "Arrowhead Pharmaceuticals Director Sells 11,600 Shares for $1 Million",
        "url": "https://urgent.news/2026/09/06/arrowhead-pharmaceuticals-director-sells-11-600-shares-for-1-million-6053760",
        "published": "2026-09-06T22:15:01.000Z"
      },
      {
        "outlet": "Nasdaq Markets",
        "title": "Arrowhead Pharmaceuticals Director Sells 11,600 Shares for $1 Million",
        "url": "https://urgent.news/2026/09/06/arrowhead-pharmaceuticals-director-sells-11-600-shares-for-1-million-6053095",
        "published": "2026-09-06T22:15:01.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}